CompletedPhase 3NCT02110147
Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria
Studying Hereditary orotic aciduria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Wellstat Therapeutics
- Principal Investigator
- Michael K. Bamat, Ph.D.Wellstat Therapeutics
- Intervention
- uridine triacetate(drug)
- Enrollment
- 4 enrolled
- Eligibility
- 19 years · All sexes
- Timeline
- 2014 – 2016
Study locations (2)
- Children's Hospital of Michigan - Specialty Center Detroit, Detroit, Michigan, United States
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02110147 on ClinicalTrials.gov